- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Astec LifeSciences Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting
31-07-2026 | 03:25 pm
31-07-2026 | 03:25 pm
Astec LifeSciences' board has approved the consolidated financial results for the quarter ended June 30, 2026. Revenue from operations stood at ₹83.56 Cr, with a net loss of ₹18.71 Cr. Basic EPS was (₹8.40).
No comments yet. Be the first to comment!